Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EMC1 antisense RNA 1 (EMC1-AS1) is a **long non-coding RNA (lncRNA)** transcribed antisense to the EMC1 gene[3][7]. It is located on chromosome 1:19,210,330-19,240,709 (hg38)[5][7]. The current literature and curated gene databases identify EMC1-AS1 as being affiliated with the lncRNA genetic class but do not describe specific functional biological roles, molecular mechanisms, or involvement in signaling pathways[3][7]. Some database associations include a link with cerebellar atrophy, but there is no published evidence that it functions as a therapeutic target, biomarker, or has reported interactions with drugs or diagnostic/monitoring value in clinical practice[3][5][7]. No safety or therapeutic challenges are reported in major gene databases[3][7].\n\n**Additional Notes:**\n- This gene should not be confused with EMC1 (ER membrane protein complex subunit 1) or EMC3-AS1, which are distinct loci with different functions and clinical contexts[1][2][4].\n- Most scientific and clinical research focuses on its gene neighbor (EMC1), and there are currently no studies identifying EMC1-AS1 as a druggable therapeutic target, receptor, enzyme, transporter, or drug interaction partner.\n\n**Summary:**\nEMC1 antisense RNA 1 (EMC1-AS1) is a non-coding RNA locus with limited functional characterization, not considered a direct therapeutic target, and has no reported direct disease or drug interactions in current scientific literature and major genetic databases[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EMC1 antisense RNA 1 (EMC1-AS1).